Reducing Central Line-Associated Bloodstream Infections in ICUs: A Systematic Review of Barriers and Facilitators and Intervention Measures.

Nurs Crit CareOct 30, 2026
Clinical ResearchInfectious Diseases

Huiqin Shi, Jingying Huang, Kailai Gu et al.

✦ AI-curated · Sources linked

In 30 seconds

This PRISMA-guided systematic review examined barriers and facilitators to implementing central line-associated bloodstream infection (CLABSI) prevention among ICU healthcare workers. It included 28 qualitative, quantitative, or mixed-methods studies identified from 1,780 records. Using the Consolidated Framework for Implementation Research, the authors synthesized 28 determinants into four themes and 16 constructs. Prominent barriers included staff knowledge gaps, inconsistent adherence to recommended practices, limited resources, and insufficient leadership support. Mapping to expert recommendations identified 11 Level 1 implementation strategies: four appeared in the included literature, while seven were potential implementation gaps.

Key findings

  • The review included 28 studies and synthesized 28 barriers and facilitators into four themes and 16 CFIR constructs.
  • Prominent barriers were staff knowledge gaps, inconsistent adherence to recommended practices, limited resources, and insufficient leadership support.
  • Of 11 Level 1 expert-endorsed strategies identified through CFIR-ERIC mapping, four were represented in the literature and seven were potential gaps.

Why it matters

The findings frame CLABSI prevention as an implementation challenge shaped by individual, organizational, and practice-related factors, not simply by the availability of guidelines. Identifying local barriers may help organizations select more relevant approaches to support consistent prevention practices and patient safety in ICUs.

What to keep in mind

The review’s findings depend on the included studies and their quality; the abstract does not report a pooled estimate of intervention effectiveness.

Source

Published in Nurs Crit Care. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.